Adaptimmune Therapeutics plc

Q1 2021 13F Holders

Symbol
ADAP
CUSIP
00653A107
Type
Equity
Class
SPONDS ADR
Num filings
91
Total reported value, excl. options
$624 M
Manager Report Date Value ($000) Shares Option Type